TrialWorld journal of gastroenterology2019

Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients.

Nicole Loo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.